The latest price target for Global Medical REIT (NYSE:GMRE) was reported by Berenberg on October 18, 2024. The analyst firm set a price target for $11.75 expecting GMRE to rise to within 12 months (a possible 49.49% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Global Medical REIT (NYSE:GMRE) was provided by Berenberg, and Global Medical REIT initiated their buy rating.

There is no last upgrade for Global Medical REIT

The last downgrade for Global Medical REIT Inc happened on October 10, 2022 when Baird changed their price target from N/A to N/A for Global Medical REIT Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Global Medical REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Global Medical REIT was filed on October 18, 2024 so you should expect the next rating to be made available sometime around October 18, 2025.

While ratings are subjective and will change, the latest Global Medical REIT (GMRE) rating was a initiated with a price target of $0.00 to $11.75. The current price Global Medical REIT (GMRE) is trading at is $7.86, which is within the analyst’s predicted range.